Learn how a new drug shows great promise for treating pancreatic by targeting the KRAS mutation, whi...
New KRAS Targeted Therapy Shows Promise Against Pancreatic Cancer
Learn how a new drug shows great promise for treating pancreatic by targeting the KRAS mutation, which fuels 90% of the disease.
Author: Memorial Sloan Kettering Cancer Center
Read Original Article